Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
KBYPF Stock Price Chart
Explore Kobayashi Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze KBYPF price movements and trends.
KBYPF Company Profile
Discover essential business fundamentals and corporate details for Kobayashi Pharmaceutical Co., Ltd. (KBYPF) to support your stock research and investment decisions.
Sector
Consumer Defensive
Industry
Household & Personal Products
IPO Date
14 Sept 2015
Employees
3.62K
Website
https://www.kobayashi.co.jpCEO
Yumi Nakagawa
Description
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, household products, skincare, and body warmers. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eyebon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods. Further, it engages in transportation, real estate management, and advertising planning and production businesses; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
KBYPF Financial Timeline
Browse a chronological timeline of Kobayashi Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 6 Nov 2025
Earnings released on 5 Aug 2025
EPS came in at $0.14 falling short of the estimated $0.17 by -13.62%, while revenue for the quarter reached $252.66M , missing expectations by -5.22%.
Earnings released on 9 May 2025
EPS came in at $0.15 falling short of the estimated $0.33 by -56.31%, while revenue for the quarter reached $217.36M , missing expectations by -7.68%.
Dividend declared on 10 Feb 2025
A dividend of $0.40 per share was announced, adjusted to $0.40.
Dividend declared on 10 Feb 2025
A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 4 Sept 2025.
Earnings released on 7 Feb 2025
EPS came in at $0.40 falling short of the estimated $0.50 by -18.68%, while revenue for the quarter reached $325.26M , missing expectations by -99.00%.
Earnings released on 8 Nov 2024
EPS came in at $0.37 falling short of the estimated $0.57 by -36.16%, while revenue for the quarter reached $1.05B , beating expectations by +245.28%.
Earnings released on 8 Aug 2024
EPS came in at $0.04 falling short of the estimated $0.33 by -88.33%, while revenue for the quarter reached $228.19M , missing expectations by -4.79%.
Earnings released on 10 May 2024
EPS came in at $0.09 falling short of the estimated $0.36 by -75.92%, while revenue for the quarter reached $240.51M , missing expectations by -0.58%.
Earnings released on 28 Mar 2024
EPS came in at $0.46 surpassing the estimated $0.40 by +15.02%, while revenue for the quarter reached $388.44M , beating expectations by +0.13%.
Dividend declared on 9 Feb 2024
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 14 Mar 2025.
Dividend declared on 9 Feb 2024
A dividend of $0.27 per share was announced, adjusted to $0.27. The dividend was paid on 5 Sept 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.67 surpassing the estimated $0.60 by +12.77%, while revenue for the quarter reached $304.40M , beating expectations by +0.98%.
Earnings released on 30 Jun 2023
EPS came in at $0.39 surpassing the estimated $0.36 by +8.77%, while revenue for the quarter reached $277.87M , beating expectations by +0.15%.
Earnings released on 31 Mar 2023
EPS came in at $0.36 surpassing the estimated $0.34 by +5.76%, while revenue for the quarter reached $252.58M , missing expectations by -2.35%.
Earnings released on 14 Feb 2023
EPS came in at $72.11 falling short of the estimated $73.86 by -2.37%, while revenue for the quarter reached $400.72M , beating expectations by +6.22%.
Dividend declared on 14 Feb 2023
A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend was paid on 7 Mar 2024.
Dividend declared on 14 Feb 2023
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 7 Sept 2023.
Earnings released on 1 Nov 2022
EPS came in at $87.99 falling short of the estimated $88.32 by -0.37%, while revenue for the quarter reached $297.49M , beating expectations by +1.27%.
Earnings released on 3 Aug 2022
EPS came in at $54.70 surpassing the estimated $48.41 by +12.99%, while revenue for the quarter reached $284.12M .
Earnings released on 27 Apr 2022
EPS came in at $44.87 falling short of the estimated $47.06 by -4.65%, while revenue for the quarter reached $266.98M .
Earnings released on 4 Feb 2022
EPS came in at $61.94 falling short of the estimated $62.77 by -1.32%, while revenue for the quarter reached $413.79M .
Dividend declared on 4 Feb 2022
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 9 Mar 2023.
Dividend declared on 4 Feb 2022
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 8 Sept 2022.
Earnings released on 28 Oct 2021
EPS came in at $89.58 surpassing the estimated $86.02 by +4.14%, while revenue for the quarter reached $364.55M .
Earnings released on 29 Jul 2021
EPS came in at $54.42 falling short of the estimated $55.25 by -1.50%, while revenue for the quarter reached $330.96M .
Earnings released on 27 Apr 2021
EPS came in at $46.42 surpassing the estimated $42.17 by +10.08%, while revenue for the quarter reached $273.84M .
Earnings released on 1 Feb 2021
EPS came in at $50.50 falling short of the estimated $58.41 by -13.54%, while revenue for the quarter reached $439.99M .
Dividend declared on 1 Feb 2021
A dividend of $0.40 per share was announced, adjusted to $0.40. The dividend was paid on 9 Mar 2022.
Dividend declared on 1 Feb 2021
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 9 Sept 2021.
Earnings released on 27 Oct 2020
EPS came in at $90.07 surpassing the estimated $74.86 by +20.32%, while revenue for the quarter reached $368.22M , beating expectations by +19.56K%.
Dividend declared on 31 Jan 2020
A dividend of $0.42 per share was announced, adjusted to $0.42. The dividend was paid on 5 Mar 2021.
KBYPF Stock Performance
Access detailed KBYPF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.